<DOC>
	<DOCNO>NCT01487226</DOCNO>
	<brief_summary>Purpose Primary endpoint - To evaluate 3-year disease free survival Second endpoint - To evaluate 3-year &amp; 5-year overall survival To analyze toxicity quality life</brief_summary>
	<brief_title>Adjuvant Chemotherapy Patients With Lymph Node Metastasis After Radical Surgery Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>cervical cancer stage Ia2IIa histology ; squamous , adeno , adenosquamous subtype age ; 20∼70 year performance status ; GOG 0∼2 medical illness hematologic , renal , hepatic function ; normal grossly residual disease histologically confirm lymph node metastases parametrial extension negative resection margin number retrieve lymph node ; ≥ 20 patient grade 2 peripheral neuropathy patient uncontrolled infection</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Cervical cancer</keyword>
</DOC>